Against the backdrop of an expanding fertility treatment market, Kitazato Corporation's sales grew in Japan and overseas in the first quarter of the fiscal year ending March 2027. Revenue was approximately ¥3 billion, operating profit approximately ¥1.5 billion and net profit approximately ¥1 billion, representing substantial year-on-year increases.
According to the summary of 北里ホールディングス' earnings report, revenue for the first quarter of the fiscal year ending March 2027 was approximately ¥3 billion, while operating profit was approximately ¥1.5 billion and net profit approximately ¥1 billion, all showing substantial year-on-year increases. Sales in particular grew in Japan and overseas against the backdrop of an expanding fertility treatment market.
Looking at recent performance trends, the past six quarters have generally been flat. Net profit margin and operating profit margin declined slightly, while the equity ratio and EPS remained stable.
The date of the next earnings announcement has not been determined, and the timing of future financial disclosures is expected to attract attention.
This report contains information stating that a Yahoo! JAPAN ID login is required to access the published analyst forecasts.
The earnings report summary is dated 31 July 2026, and 北里ホールディングス' performance trends are being monitored amid changes in the market environment.